Companies / Astria Therapeutics, Inc.

Astria Therapeutics, Inc.

ATXSCIK 1454789BOSTON, MAcatabasis.com ↗

Financials · FY2017

Revenue$500.0K
Net income$-94.26M
Total debt$833.0K
Cash$96.28M
Diluted EPS$-1.68
Shares outstanding57.1M

Ownership

57.1M shares outstanding · as of Oct 31, 2025
6.6%10%+ / strategic
Ownership
10%+ / strategic6.62%3,776,154
Public float93.38%53,308,684

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 14

View all →
Insider% of sharesShares
Komjathy AndrewChief Commercial Officer
0.00%0
Milne Jill C.CEOCEO and President · Director
0.00%0
Violin JonathanDirector
0.00%0
Agarwal SunilDirector
——
Bate KennethDirector
——
Beck Joanne T.Director
——
Callori FredDirector
——
Clauser NoahChief Financial Officer
——
Cole Hugh MDirector
——
Harshbarger BenjaminChief Legal Officer
——

Institutional holders 0

HolderValue% of shares
No institutional holders on file.

Activity

—View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
No activity matches these filters.

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Glazer Capital, LLCPassive13G/A—3,776,154—
Vestal Point Capital, LPPassive13G/A———